NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.

Optic nerve involvement, while unusual at presentation, with around 0.9% affected, remains the most common cranial nerve to be affected by relapsing polychondritis and over the entire disease course, ...

Cosentyx missed its main goal in a Phase 3 GCA study, but showed lower steroid use. Novartis plans full review of the trial ...

“While the phase 3 results of GCAptAIN did not replicate the positive outcomes observed in the phase 2 trial, we remain committed to continuing to drive scientific progress and deepening the ...

Novartis (NVS) stock slips as the company's anti-inflammatory agent Cosentyx fails primary goal in a Phase 3 trial for giant ...

Novartis said on Thursday that its Cosentyx drug had failed in a late-stage trial on adults with giant cell arteritis (GCA), ...

Giant Cell Arteritis: An Update on Diagnosis and Management Elizabeth Hazel, MD, FRCPC; Michael Starr, MD, FRCPC Disclosures Geriatrics and Aging. 2007;10 (6):389-392. 1 ...

Novartis NVS announced that a late-stage study of its interleukin-17A inhibitor, Cosentyx (secukinumab), has failed to meet ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Objective: To investigate the relation between temporal artery biopsy (TAB) length and diagnostic sensitivity for giant cell arteritis. Methods: Histological TAB reports generated from four hospital ...

Biological age acceleration is associated with an increased risk of glaucoma and elevated intraocular pressure.